Cipher Pharmaceuticals Inc. – Trademark Portfolio
Entity Type: 03
Cipher Pharmaceuticals Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include CONZIP, LIPOFEN, and NATROBA. The owner is based in Mississauga, Ontario.
5750 Explorer Drive Suite 404
Mississauga, Ontario L4W0A9 , CA
Showing of trademarks Trademarks
Trademark Classifications
Cipher Pharmaceuticals Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Cipher Pharmaceuticals Inc. have?
Cipher Pharmaceuticals Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 abandoned.
What trademark classes does Cipher Pharmaceuticals Inc. file in?
Cipher Pharmaceuticals Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Cipher Pharmaceuticals Inc.'s most well-known trademarks?
Cipher Pharmaceuticals Inc.'s registered trademark portfolio includes well-known marks such as CONZIP, LIPOFEN, and NATROBA. These are among 3 currently registered trademarks in the portfolio.
What is Cipher Pharmaceuticals Inc.'s trademark registration success rate?
Cipher Pharmaceuticals Inc. has a 43% trademark registration rate, with 3 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.